Study of GNX102 in Patients With Advanced Solid Tumors
Clinical trial NCT04250597 · TERMINATED
Trial details
- NCT number
- NCT04250597
- Sponsor
- GlycoNex, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2023-07-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.